Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow, Mitochondrial Function and Leg Performance in Patients With Peripheral Artery Disease

NCT03493412 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT03493412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03493412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow, Mitochondrial Function and Leg Performance in Patients With Peripheral Artery Disease
Lead sponsor
University of Nebraska
Phase
Phase 4
Overall status
Withdrawn
Start date
July 1, 2019
Completion date
October 1, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, peripheral artery disease